904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma

• Thomas Mace,
• Gregory Lesinski,
• Chrystal Paulos,
• Megan Wyatt,
• Cameron Herting,
• Michael Ware,
• Juan Sarmiento,
• Shishir Maithel,
• Bassel El-rayes,
• Maggie Phillips

Affiliations

Thomas Mace

Aff1 grid.261331.40000000122857943The Ohio State University Columbus OH USA

Gregory Lesinski

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Chrystal Paulos

1Emory University, Atlanta, GA, USA

Megan Wyatt

1Emory University, Atlanta, GA, USA

Cameron Herting

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Michael Ware

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Juan Sarmiento

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Shishir Maithel

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Bassel El-rayes

1Winship Cancer Institute of Emory University, Decatur, GA, USA

Maggie Phillips

Medical director Travellers` Medical and Vaccination Centre, Adelaide, Australia